/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
With a market cap of $18.4 billion, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets a broad portfolio of orthopedic reconstructive implants, sports medicine and trauma products, dental solutions, and surgical technologies, including robotic-assisted systems.
The company is slated to announce its fiscal Q4 2025 results soon. Ahead of the event, analysts expect Zimmer Biomet to report an adjusted EPS of $2.38, up 3% from $2.31 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in each of the past four quarterly reports while missing on another occasion.